Stimulation of CD40 in human bladder carcinoma cells inhibits anti-Fas/APO-1 (CD95)-induced apoptosis

被引:0
|
作者
Jakobson, E [1 ]
Jönsson, G [1 ]
Björck, P [1 ]
Paulie, S [1 ]
机构
[1] Univ Stockholm, Dept Immunol, S-10691 Stockholm, Sweden
关键词
D O I
10.1002/(SICI)1097-0215(19980911)77:6<849::AID-IJC9>3.0.CO;2-U
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CD40 and the CD95 (Fas/APO-1 antigen) are both members of the tumor necrosis factor receptor family. Whereas CD40 mediates a strong growth stimulatory signal in B cells, engagement of the CD95 receptor leads to growth inhibition and induction of apoptosis. As it has been reported that CD40 activation may rescue B cells from undergoing apoptosis, we were interested to see whether it had a similar effect in other cells expressing the CD40 receptor. We used epithelial tumor cells from the urinary bladder, a cell type that frequently expresses CD40 but for which no clear function of the molecule has been assigned. We found that the ligation of CD95 with the antibody anti-APO-l induced apoptosis in most of the cell lines tested. Stimulation of CD40 with antibodies or a soluble construct of the CD40 ligand was shown to protect cells from apoptosis, as demonstrated by their ability to suppress the growth inhibition exerted by the anti-APO-l antibody. Our results show that CD40 stimulation make cells less vulnerable to apoptosis induced via CD95 and suggest that CD40 expression on epithelial tumors may be associated with cell survival. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:849 / 853
页数:5
相关论文
共 50 条
  • [31] Apoptosis of cultured neuroblastoma cells is induced by ceramide and not by ligation of the Fas/Apo-1/CD95 receptor
    Barthlen, W
    Schäfer, J
    Girgert, R
    Schuster, M
    Schweizer, P
    CHEMOTHERAPY, 1999, 45 (04) : 258 - 267
  • [32] Drug induced cytotoxicity in leukemia cells involves the CD95 (APO-1/FAS) pathway of apoptosis
    Friesen, C
    Herr, I
    Los, M
    Debatin, KM
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 367 - 367
  • [33] Apoptosis of cultured Langerhans cells is mediated by the CD95 (APO-1/FAS)/CD95L-system
    vonStebut, E
    Philipp, S
    Wurz, C
    Ringling, M
    Kolde, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 406 - 406
  • [34] Modulation of CD95 (APO-1/Fas)-induced hepatocyte death by NO
    Galle, PR
    Strand, D
    Su, Z
    Theobald, M
    Harris, CC
    Strand, S
    CYTOKINES IN LIVER INJURY AND REPAIR, 2002, 125 : 25 - 30
  • [35] Fas antigen/APO-1 (CD95) expression on myeloma cells
    Shima, Y
    Nishimoto, N
    Yoshizaki, K
    Kishimoto, T
    LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 521 - +
  • [36] Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells
    Villunger, A
    Egle, A
    Kos, M
    Hartmann, BL
    Geley, S
    Kofler, R
    Greil, R
    CANCER RESEARCH, 1997, 57 (16) : 3331 - 3334
  • [37] Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes
    D Bouscary
    J De Vos
    M Guesnu
    K Jondeau
    F Viguier
    J Melle
    F Picard
    F Dreyfus
    M Fontenay-Roupie
    Leukemia, 1997, 11 : 839 - 845
  • [38] Human melanoma cells do not express Fas (Apo-1/CD95) ligand
    Chappell, DB
    Zaks, TZ
    Rosenberg, SA
    Restifo, NP
    CANCER RESEARCH, 1999, 59 (01) : 59 - 62
  • [39] Regulation of apoptosis through CD95 (APO-1/FAS) receptor/ligand
    Debatin, KM
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 228 - 228
  • [40] Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes
    Bouscary, D
    DeVos, J
    Guesnu, M
    Jondeau, K
    Viguier, F
    Melle, J
    Picard, F
    Dreyfus, F
    FontenayRoupie, M
    LEUKEMIA, 1997, 11 (06) : 839 - 845